TrialHuman vaccines & immunotherapeutics2016

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.

Barbara Romanowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.